Von Hippel-lindau Disease
📧 Sign up to get email alerts when something new happens for Von Hippel-lindau Disease.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-01-13EMA Authorised: Welireg (belzutifan) — Merck Sharp & Dohme B.V.
The European Medicines Agency authorised Welireg (belzutifan) for renal cell carcinoma and von Hippel-Lindau disease, in the EU under condit…
-
EMA approval · 2024-12-13First medicine to treat rare genetic disorder causing cysts and tumours
The European Medicines Agency approved belzutifan (brand name Welireg) as the first medicine to treat von Hippel-Lindau disease and advanced…